Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
May 14, 2020

ID.Vet launches ELISA serological test

By Chloe Kent

French company ID.Vet has launched an enzyme-linked immunosorbent assay (ELISA) serological test to detect the presence of Covid-19 antibodies.

The company said the test has a specificity of 99.9%, significantly lowering the rate of false positive results. More than a million of the tests have already been produced. The test does not require any specific equipment and the assay can be performed on any open automated immunoassay platform or manually.

The product is CE marked and available for immediate shipping.

ID.Vet CEO Philippe Pourquier said: “We mobilised all our scientific know-how and resources to rapidly develop this test. Thanks to our automated production line and modern infrastructure, we are able to produce millions of tests to meet worldwide demand.”

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU